Congresess

Genes and environment interplay in Neuropsychiatric Disorders

Mojácar (Almería)

October 16 - 20 2003

The content of this congress, together with other contributions on the topic, are collected in vol. 7 of the series "Strategies for studying brain disorders".

PROGRAMME

• Tomas Palomo, Spain
  Opening Remarks
• Bita Moghaddam, USA
  A few words in memory of Patricia Goldman-Rakic

S1. THE ROLE OF GENES AND ENVIRONMENT IN THE SHAPING OF BEHAVIOUR

• Donald F. Klein, USA
  Genes, Environment and Psychiatry Nosology
• Pier V. Piazza, France
  Environmental influence on genetic regulation of behaviour
• Ayman Fanous, USA
  Genetic relationship between major depression, personality and schizophrenia
• Jesús Avila, Spain
  Tau phosphorylation and assembly
• Isidro Ferrer, Spain
  Participation of select active kinases in tau hyperphosphorylation in Alzheimer's disease, and in sporadic and familial taupathies
• Peter Kalivas, USA
  Gene and environmental regulation of drug addiction:  can we forget to be addicted?

S2. SCHIZOPSYCHOTIC DISORDERS

• Bita Moghaddam, USA
  Stress activation of glutamate neurotransmission in the prefrontal cortex: Implications for dopamine-associated disorders
• Therese M. Jay, France
  Cellular mechanisms of hippocampal/frontal circuits
• Gavin Reynolds, UK
  Calcium binding protein markers of GABA deficits in schizophrenia
• Mark Geyer, USA
  Neurobiological measures of schizophrenia spectrum disorders
• José Borrell, Spain
  Neurobiological consequences of prenatal immune challenge
• Brien P. Riley, USA
  Linkage studies of schizophrenia
• Robin Murray, UK
  The role of endophenotypic abnormalities in the relatives of people with schizophrenia

S3. COGNITIVES DISORDERS

• Trevor Archer, Sweden
  Neurobehavioral deficits associated with apoptotic neurodegeneration and vulnerability for ADHD
• Jorge H. Medina, Argentina
  Gene expression during memory formation
• José M. Delgado-García, Spain
  The use of conscious mice in the study of learning and memory processes
• Eduardo Rodriguez-Farré, Spain
  Xenobiotic-induced neuropsychiatric disorders: the case of methylmercury
• Richard Beninger, Canada
  The role of signalling molecules in incentive learning
• Martín Cammarota, Brazil
  Hippocampal glutamate receptors in fear memory consolidation
• Ivan Izquierdo, Brazil
  The inhibition of acquired fear

S6. DRUG ABUSE

• Javier Fernández, Spain
  Cannabinoids and gene expression during brain development
• Janet Hoenicka, Spain
  CNR1 gene variants and behavioural disorders
• Sari Izenwasser, USA
  The role of the dopamine transporter in cocaine abuse
• Giancarlo Colombo, Italy
  Role of GABA-B receptor in alcohol dependence.
• Gabriel Rubio, Spain
  Polymorphism TAq1 and alcohol dependence
• Markus Heilig, Sweden
  Functional genomics strategies to identify susceptibility genes and treatment targets in alcohol dependence

S5. AFFECTIVE DISORDERS

• Rene Hen, USA
  Influence of postnatal development and hippocampal neurogenesis on anxiety and depression
• Antonio Bulbena, Spain
  Susceptibility factors in panic disorder
• Jorge Manzanares, Spain
  Role of the endogenous cannabinoid CB1 receptor in the regulation of anxiety
• Ian Reid, UK
  Synaptic plasticity and antidepressant treatment: New cells, new connections

S4. MOVEMENTS DISORDERS

• Richard Kostrezwa, USA
  Dopamine agonist priming in intact and dopamine-lesioned rats: implications for motor dyskinesias
• Alberto Ferrús, Spain
  Ariadne, a Parkin-related protein of Drosophila, regulates membrane biogenesis through the ubiquitin pathway
• José Javier Lucas, Spain
  Neuronal induction of the immunoproteasome in Huntington’s disease

S7. FROM GENES TO BEHAVIOUR

• Douglas Blackwood, UK
  Phenotypes and genotype at a chromosome 1q42 locus linked to schizophrenia and Bipolar Illness
• Pierre Sokoloff, France
  Brain-derived neurotrophic factor (BDNF) bridges the gap between dopamine and glutamate dysfunctions in schizophrenia.
• Cobi J. Heijnen, The Netherlands
  Neonatal glucocorticoids and the developing brain: short-term treatment with life-long consequences
• Peter Eriksson, Sweden
  The spectre of hope in the neurodegenerative diseases: therapeutic potential of stem cells
• Anil K. Malhotra, USA
  Genetic and environmental factors in the treatment of neuropsychiatric disorders
• Michel Le Moal, France
  Environmentally induced long-term structural changes: cues for functional orientation and vulnerabilities